Practical Guide to the Identification and Diagnosis of Asthma-COPD Overlap (ACO)

References

• Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379(9823):1341–1351.
   PubMed Web of Science ®Google Scholar
• Barrecheguren M, Esquinas C, Miravitlles M. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr Opin Pulm Med. 2015;21:74–79.
   PubMed Web of Science ®Google Scholar
• Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015;3(6):435–442.
   PubMed Web of Science ®Google Scholar
• Kitaguchi Y, Komatsu Y, Fujimoto K, Hanaoka M, Kubo K. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int J Chron Obstruct Pulmon Dis. 2012;7:283–289.
   PubMed Web of Science ®Google Scholar
• Louie S, Zeki AA, Schivo M, Chan AL, Yoneda KY, Avdalovic M, Morrissey BM, Albertson TE. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev Clin Pharmacol. 2013;6(2):197–219. doi:10.1586/ecp.13.2.
   PubMed Web of Science ®Google Scholar
• Hayden LP, Cho MH, Raby BA, Beaty TH, Silverman EK, Hersh CP; COPDGene Investigators. Childhood asthma is associated with COPD and known asthma variants in COPDGene: a genome-wide association study. Respir Res. 2018;19(1):209.
   PubMedGoogle Scholar
• Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ, Crapo JD, Hersh CP; COPDGene Investigators. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12:127.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soriano JB, Ancochea J, Muñoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, García-Rio F. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med. 2013;107(7):1053–1060. doi:10.1016/j.rmed.2013.03.007.
   PubMed Web of Science ®Google Scholar
• Menezes AM, de Oca MM, Perez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, Muiño A, Jardim JRB, Valdivia G, Tálamo C. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145:297–304.
   PubMed Web of Science ®Google Scholar
• Cosio BG, Soriano JB, López-Campos JL, Calle-Rubio M, Soler-Cataluña JJ, de-Torres JP, Marín JM, Martínez-Gonzalez C, de Lucas P, Mir I, et al. Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort. Chest. 2016;149:45–52.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Makita H, Konno S, Shimizu K, Kimura H, Kimura H, Nishimura M; Hokkaido COPD Cohort Study Investigators. Asthma-like features and clinical course of chronic obstructive pulmonary disease. An analysis from the Hokkaido COPD Cohort Study. Am J Respir Crit Care Med. 2016;194(11):1358–1365 doi:10.1164/rccm.201602-0353OC.
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Cosío B, Izquierdo JL, López-Campos JL, Marín JM, Agüero R, Baloira A, Carrizo S, Esteban C, Galdiz JB, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol. 2012;48(9):331–337 doi:10.1016/j.arbr.2012.06.017.
   PubMed Web of Science ®Google Scholar
• Kankaanranta H, Harju T, Kilpeläinen M, Mazur W, Lehto JT, Katajisto M, Peisa T, Meinander T, Lehtimäki L. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the Finnish guidelines. Basic Clin Pharmacol Toxicol. 2015;116(4):291–307 doi:10.1111/bcpt.12366.
   PubMed Web of Science ®Google Scholar
• Koblizek V, Chlumsky J, Zindr V, Neumannova K, Zatloukal J, Zak J, Sedlak V, Kocianova J, Zatloukal J, Hejduk K, et al. Czech Pneumological and Phthisiological Society Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157(2):189–201. doi:10.5507/bp.2013.039.
   PubMed Web of Science ®Google Scholar
• GINA and Global Initiative for Chronic Obstructive Lung Disease (GOLD) [webpage on the Internet]. Asthma, COPD, and asthma-COPD overlap syndrome. GINA and Global Initiative for Chronic Obstructive Lung Disease; 2015. Available from: http://www.goldcopd.org/asthma-copd-overlap.html. Accessed January 10, 2019.
   Google Scholar
• Sin DD, Miravitlles M, Mannino DM, Soriano JB, Price D, Celli BR, Leung JM, Nakano Y, Park HY, Wark PA, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J. 2016;48(3):664–673. doi:10.1183/13993003.00436-2016.
   PubMed Web of Science ®Google Scholar
• Plaza V, Álvarez F, Calle M, Casanova C, Cosío BG, López-Viña A, Pérez de Llano L, Quirce S, Román-Rodríguez M, Soler-Cataluña JJ, et al. Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA). Arch Bronconeumol. 2017;53(8):443–449. doi:10.1016/j.arbres.2017.04.002.
   PubMed Web of Science ®Google Scholar
• García-García MC, Hernández-Borge J, Barrecheguren M, Miravitlles M. The challenge of diagnosing a mixed asthma-COPD (ACOS) phenotype in clinical practice. Ther Adv Respir Dis. 2016;10:175–178. doi:10.1177/1753465816630209.
   PubMed Web of Science ®Google Scholar
• Anzueto A, Miravitlles M. Considerations for the correct diagnosis of chronic obstructive pulmonary disease and its management with bronchodilators. Chest. 2018;154:242–248. doi:10.1016/j.chest.2018.02.023.
   PubMed Web of Science ®Google Scholar
• Barrecheguren M, Esquinas C, Miravitlles M. How can we identify patients with asthma-COPD overlap syndrome in clinical practice? Arch Bronconeumol. 2016;52:59–60.
   PubMed Web of Science ®Google Scholar
• [GEMA (4.0). Guidelines for Asthma Management]. Arch Bronconeumol. 2015;51(Suppl 1):2–54.
   PubMedGoogle Scholar
• Miravitlles M, Alvarez-Gutierrez FJ, Calle M, Casanova C, Cosio BG, López-Viña A, Pérez de Llano L, Quirce S, Roman-Rodríguez M, Soler-Cataluña JJ, et al. Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines. Eur Respir J. 2017;49(5):1700068. doi:10.1183/13993003.00068-2017.
   PubMed Web of Science ®Google Scholar
• Barrecheguren M, Román-Rodríguez M, Miravitlles M. Is a previous diagnosis of asthma a reliable criterion for asthma–COPD overlap syndrome in a patient with COPD? Int J Chron Obstruct Pulmon Dis. 2015;10:1745–1752.
   PubMed Web of Science ®Google Scholar
• Wurst KE, Rheault TR, Edwards L, Tal-Singer R, Agusti A, Vestbo J. A comparison of COPD patients with and without ACOS in the ECLIPSE study. Eur Respir J. 2016;47(5):1559–1562.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, Trigueros JA, Cosío BG, Casanova C, Riesco JA, et al. Spanish COPD guidelines (GesEPOC) 2017. Pharmacological treatment of stable chronic obstructive pulmonary disease. Arch Bronconeumol. 2017;53:324–335. doi:10.1016/j.arbres.2017.03.018.
   PubMed Web of Science ®Google Scholar
• Tommola M, Ilmarinen P, Tuomisto LE, Lehtimäki L, Haanpää J, Niemelä O, Kankaanranta H. Differences between asthma–COPD overlap syndrome and adult-onset asthma. Eur Respir J. 2017;49(5):1602383. doi:10.1183/13993003.02383-2016.
   PubMed Web of Science ®Google Scholar
• Cosentino J, Zhao H, Hardin M, Hersh CP, Crapo J, Kim V, Criner GJ; COPDGene Investigators. Analysis of asthma-chronic obstructive pulmonary disease overlap syndrome defined on the basis of bronchodilator response and degree of emphysema. Ann Am Thorac Soc. 2016;13(9):1483–1489. doi:10.1513/AnnalsATS.201511-761OC.
   PubMed Web of Science ®Google Scholar
• Marin JM, Ciudad M, Moya V, Carrizo S, Bello S, Piras B, Celli BR, Miravitlles M. Airflow reversibility and long-term outcomes in patients with COPD without comorbidities. Respir Med. 2014;108:1180–1188. doi:10.1016/j.rmed.2014.05.006.
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Celli B, Decramer M, Liu D, Burkhart D, Cassino C, Kesten S. Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008;31(4):742–750.
   PubMed Web of Science ®Google Scholar
• Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax. 2003;58(8):659–664.
   PubMed Web of Science ®Google Scholar
• Miravitlles M. Diagnosis of asthma–COPD overlap: the five commandments. Eur Respir J. 2017;49(5):1700506. doi:10.1183/13993003.00506-2017.
   PubMed Web of Science ®Google Scholar
• National Clinical Guideline Centre. (2010) Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. London: National Clinical Guideline Centre. Available from: http://guidance.nice.org.uk/CG101/Guidance/pdf/English (pages 78–81)
   Google Scholar
• Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64(8):728–735
   PubMed Web of Science ®Google Scholar
• Kerstjens HA, Overbeek SE, Schouten JP, Brand PL, Postma DS. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group. Eur Respir J. 1993;6(6):868–876.
   PubMed Web of Science ®Google Scholar
• Weiner P, Weiner M, Azgad Y, Zamir D. Inhaled budesonide therapy for patients with stable COPD. Chest. 1995;108(6):1568–1571
   PubMed Web of Science ®Google Scholar
• Bleecker ER, Emmett A, Crater G, Knobil K, Kalberg C. Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibility. Pulm Pharmacol Ther. 2008;21(4):682–688. doi:10.1016/j.pupt.2008.04.003.
   PubMed Web of Science ®Google Scholar
• Papi A, Romagnoli M, Baraldo S, Braccioni F, Guzzinati I, Saetta M, Ciaccia A, Fabbri LM. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162(5):1773–1777. doi:10.1164/ajrccm.162.5.9910112.
   PubMed Web of Science ®Google Scholar
• Queiroz CF, Lemos AC, Bastos ML, Neves MC, Camelier AA, Carvalho NB, Carvalho EM. Inflammatory and immunological profiles in patients with COPD: relationship with FEV 1 reversibility. J Bras Pneumol. 2016;42(4):241–247
   PubMed Web of Science ®Google Scholar
• Albert P, Agusti A, Edwards L, Tal-Singer R, Yates J, Bakke P, Celli BR, Coxson HO, Crim C, Lomas DA, et al. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. Thorax. 2012;67(8):701–708.
   PubMed Web of Science ®Google Scholar
• Pérez de Llano L, Cosío BG, Miravitlles M, Plaza V; CHACOS study group. Accuracy of a new algorithm to identify asthma-COPD overlap (ACO) patients in a cohort of patients with chronic obstructive airway disease. Arch Bronconeumol. 2018;54(4):198–204. doi:10.1016/j.arbres.2017.10.007.
   PubMed Web of Science ®Google Scholar
• Christenson SA, Steiling K, van den Berge M, Hijazi K, Hiemstra PS, Postma DS, Lenburg ME, Spira A, Woodruff PG. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(7):758–766. doi:10.1164/rccm.201408-1458OC.
   PubMed Web of Science ®Google Scholar
• Cosío BG, Pérez de Llano L, Lopez Viña A, Torrego A, Lopez-Campos JL, Soriano JB, Martinez Moragon E, Izquierdo JL, Bobolea I, Callejas J, et al.; on behalf of the CHACOS study group. Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome? Eur Respir J. 2017;49(5).pii: 1602397.
   PubMed Web of Science ®Google Scholar
• Wagener AH, de Nijs SB, Lutter R, Sousa AR, Weersink EJ, Bel EH, Sterk PJ. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. Thorax. 2015;70(2):115–120.
   PubMed Web of Science ®Google Scholar
• De Llano LP, Cosío BG, Iglesias A, de Las Cuevas N, Soler-Cataluña JJ, Izquierdo JL, López-Campos JL, Calero C, Plaza V, Miravitlles M, et al. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach. Int J Chron Obstruct Pulmon Dis. 2018;13:591–601. doi:10.2147/COPD.S153694.
   PubMed Web of Science ®Google Scholar
• Diamant Z, Brusselle G, Russell RE. Toward effective prescription of inhaled corticosteroids in chronic airway disease. Int J Chron Obstruct Pulmon Dis. 2018;13:3419–3424. doi:10.2147/COPD.S174216.
   PubMed Web of Science ®Google Scholar